Clinical Trial Update: Trial of Sirolimus and Methotrexate in Relapsed/Refractory Lymphoblastic Leukemia and Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sirolimus and methotrexate in relapsed/refractory lymphoblastic leukemia and lymphoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Leukemia
• Lymphoma

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Sirolimus (Sirolimus)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Cancer, Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2019-08-06